No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Healthcare Plans
Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.
www.centene.comNo one on the platform currently holds 0HVB.L.
No tracked institution reports a position in 0HVB.L as of their last filing.
No one on the platform has traded 0HVB.L yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | 19.4% | 11.9% | ||||
| Profit Margin % | -3.4% | 0.5% | 1.0% | |||
| Free Cash Flow Margin % | 2.2% | 2.7% | 2.6% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $195.9B | +1.2% | $4.80 | $4.67–$4.95 | — | 1 |
| 2027 | $193.5B | -1.2% | $5.26 | $5.11–$5.42 | — | 1 |
| 2028 | $200.0B | +3.4% | $6.48 | $6.30–$6.68 | — | 1 |
| 2029 | $207.1B | +3.5% | $8.15 | $7.92–$8.40 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-28 | $1.09 | $2.51 | +130.3% |
| 2026-04-28 | $2.23 | $3.37 | +51.1% |
| 2026-02-06 | $-1.22 | $-1.19 | +2.6% |
| 2025-10-29 | $-0.14 | $0.50 | +445.4% |
| 2025-07-25 | $0.11 | $-0.16 | -243.4% |
| 2025-04-25 | $2.52 | $2.90 | +15.1% |
| 2025-02-04 | $0.49 | $0.80 | +62.1% |
| 2024-10-25 | $1.35 |
| $1.62 |
| +20.0% |
| $16.9B |
| — |
| 0J8Z.LIllumina, Inc. | $209.93 | +0.93% | $31.8B | — |
| 0JSY.LLabcorp Holdings Inc. | $311.32 | +0.68% | $25.7B | — |
Source: Financial Modeling Prep · peers by sector/industry